INTRODUCTION {#S1}
============

Long-term neuroadaptations induced by chronic alcohol exposure are critical for the development of alcohol addiction (here-after equated with 'alcoholism'), and can in part be modeled in experimental animals.^[@R1],[@R2]^ Using these models, epigenetic processes have emerged as an important mechanism in the regulation of alcohol seeking and taking, as well as associated changes in gene expression profiles. For instance, inhibition of DNA methyltransferase and histone deacetylase (HDAC) was recently shown to prevent escalation of voluntary alcohol intake, and restored alcohol-induced gene expression changes.^[@R3],[@R4]^ In the amygdala, ethanol exposure was associated with increased histone acetylation, whereas withdrawal was associated with decreased histone acetylation.^[@R5]^ Furthermore, treatment with the HDAC inhibitor trichostatin A prevented the development of alcohol withdrawal-related anxiety in Sprague---Dawley rats.^[@R6],[@R7]^ Similar results were found with the selectively bred alcohol-preferring (P) rats. P rats showed higher HDAC2 expression associated with higher HDAC activity in the central amygdala. Moreover, HDAC2 knockdown in the central amygdala attenuated anxiety-like behaviors and voluntary drinking in P rats, suggesting a role of HDAC2 in anxiety and alcoholism.^[@R8]^

Although the role of DNA methylation and histone acetylation in neuroadaptations underlying alcohol-related behaviors has been well studied, little is known about the role of histone methylation and its related enzymes in this context. Recently, however, two studies demonstrated that the histone methyltransferase G9a may be involved in cocaine-induced plasticity and morphine-associated behaviors,^[@R9],[@R10]^ suggesting that histone methylation may also be relevant for addiction.

In rats, a prolonged history of alcohol dependence results in a persistent increase in alcohol self-administration, increased aversion-resistant alcohol intake and increased propensity to relapse.^[@R2],[@R11]--[@R15]^ These traits, collectively labeled 'postdependent', are to a large extent driven by processes in the dorsomedial prefrontal cortex (dmPFC).^[@R4],[@R16],[@R17]^ Alcohol vapor inhalation, as opposed to liquid diet administration, more readily leads to physical dependence, as indicated by withdrawal symptoms that peak between 12 and 24 h after cessation of alcohol exposure.^[@R18]^ In addition, prolonged chronic intermittent exposure to alcohol vapor induces neuroadaptations that persist beyond the acute withdrawal symptoms. We have previously shown that alcohol drinking is persistently increased 3 weeks after recovery from vapor exposure-induced dependence.^[@R15]^ At this same time point, we observed changes in DNA methylation and expression of genes related to synaptic plasticity pathways.^[@R4]^ Because the effects of acute alcohol withdrawal did not confound these findings, these studies showed that long-term neuroadaptations underlie enduring increases in alcohol consumption and vulnerability for relapse.

In the present study, we sought to test the hypothesis that histone-modifying enzymes control long-term gene expression changes that contribute to neuroadaptations and enduring alcohol-seeking behaviors in dependent animals. We focused on the dmPFC because of its prominent role in behavioral consequences of alcohol dependence,^[@R19]^ and our recent work indicating persistent dependence-induced reprogramming of gene expression in this region.^[@R4],[@R16],[@R20]^

We found that the histone methyltransferase PR domain containing 2, with ZNF domain (PRDM2, also called RIZ1), was dysregulated in the dmPFC of postdependent animals. PRDM2 is a tumor suppressor protein whose inactivation has an important role in several human cancers.^[@R21]--[@R25]^ Unlike some other histone methyltransferases, which can exhibit promiscuity for histone tail modification sites or degree of methylation at a particular site, PRDM2 specifically modifies histone H3 on lysine 9,^[@R26]^ where it preferentially catalyzes the addition of a single methyl group (histone 3 at the lysine 9 residue (H3K9me1)).^[@R27]^ One recent study reported an increase in acetylation specifically at H3K9 in the PFC of alcohol-exposed mice, suggesting that this histone tail residue, in particular, may be important for alcohol-induced gene expression changes.^[@R28]^ It has been shown that a dietary deficiency of the methyl donor S-adenosyl-methionine or treatment with the methyltransferase reaction product S-adenosyl-homocysteine inhibits PRDM2 histone methyltransferase activity, suggesting that PRDM2 activity can be regulated by environmental factors.^[@R26]^ Hypermethylation on the *Prdm2* promoter is associated with decreased *Prdm2* mRNA expression in cancer.^[@R29]^ *Prdm2* downregulation is associated with poor prognosis in gliomas and neuroblastomas, suggesting that it could have a role in the brain.^[@R30],[@R31]^ However, no studies, to date, have identified a role for this enzyme in psychiatric diseases.

Our previous study^[@R4]^ showed that postdependent neuroadaptations involved DNA methylation changes in the mPFC, and previous studies showed that *Prdm2* is likely to be regulated by DNA methylation. Here, we hypothesized that downregulation of *Prdm2* in the mPFC of postdependent rats may be one of the mechanisms through which DNA hypermethylation induces alcohol-seeking behavior. To address this hypothesis, we examine whether dysregulation of *Prdm2* in the mPFC contributes to the long-term behavioral and molecular changes induced by a history of alcohol dependence.

MATERIALS AND METHODS {#S2}
=====================

Animals {#S3}
-------

Male Wistar rats (200--225 g; Charles River, Wilmington, MA, USA) were housed under a reverse light cycle with food and water *ad libitum*, and were habituated to the facility and handled before experiments. Testing took place during the dark phase. Procedures were approved by the NIAAA Animal Care and Use Committee.

Dependence induction {#S4}
--------------------

Dependence was induced using chronic intermittent alcohol vapor exposure as described.^[@R32]^ Briefly, postdependent rats were exposed to alcohol vapor for 14 h each day (on at 19:30 hours, off at 09:30 hours) for 7 weeks, resulting in blood alcohol concentrations between \~200 and \~300mg dl^−1^. Controls were kept in identical chambers with normal air flow. Once weekly, blood was collected from the lateral tail vein. Blood alcohol concentrations were assessed using quantitative gas chromatography.^[@R16]^ All molecular and biochemical analyses in these studies were conducted using dorsomedial prefrontal cortex (dmPFC, coordinates relative to bregma: +2.76 to +3.72; Paxinos and Watson^[@R33]^) collected 3 weeks after the end of the last exposure to assess persistent, rather than intoxication- or withdrawal-related, effects of alcohol exposure.^[@R2],[@R18]^

Surgery {#S5}
-------

For the lentiviral microinjection, rats received two injections bilaterally (1 μl per injection; rate: 0.25 μl min^−1^) directly into the dmPFC (coordinates relative to bregma: anterior--posterior: +2.5 and +3 mm, medial--lateral: ±0.7 mm, dorsal---ventral −3.5 mm; Paxinos and Watson^[@R33]^) of a lentiviral vector containing a short hairpin RNA (shRNA) targeting *PRDM2* (5′-GGAGCCCAAGTCCTTGTAAAT-3′; titer: 9.7 × 10^9^ TU ml^−1^; Sigma, St Louis, MO, USA; [Supplementary Figure 1](#SD2){ref-type="supplementary-material"}) and a scrambled control (titer: 2.9 × 10^9^ TU ml^−1^). Rats were subjected to behavioral studies after a 1-week recovery period.

For the RG-108 experiments, rats received continuous infusion of RG-108 (Sigma; 100 pM dissolved in 5% 2-hydroxypropyl β-cyclodextrin (w v^−1^)) into the dmPFC (coordinates relative to bregma: anterior---posterior: +2.5 mm, medial-lateral: ± 1.5 mm, dorsal-ventral: −3.5 mm, 10°). The rats underwent surgery 2 weeks after the end of alcohol exposure using the osmotic minipumps 2004 (0.25 μl h^−1^; 28 days; Alzet, Cupertino, CA, USA) for dmPFC infusion.

RNA extraction {#S6}
--------------

Bilateral samples from the dmPFC were dissected out as described,^[@R34]^ and stored at −80 °C. RNA was extracted from dmPFC using PureLink RNA Mini Kit (Life Technologies, Carlsbad, CA, USA), following the manufacturer's instructions.

Quantitative real-time PCR {#S7}
--------------------------

Total RNA was reverse transcribed into cDNA using qScript cDNA SuperMix (Quanta Biosciences, Gaithersburg, MD, USA). The reactions were run on a Veriti 96-well Fast Thermal Cycler (Life Technologies). Inventoried TaqMan Gene expression assay probes *(Prdm2:* Rn011516793_m1 and *Gapdh:* Rn4308313; Life Technologies) were used to assess the expression of rat target genes on an ABI 7900HT Fast Real-time PCR System (Life Technologies). Target gene expression was quantified with respect to glyceraldehyde 3-phosphate dehydrogenase using RQ Manager 1.2 (Life Technologies) by calculating an RQ value using 2^−ΔΔCT^ analysis.^[@R35]^

Chromatin immunoprecipitation {#S8}
-----------------------------

Unless specified, reagents were purchased from Sigma. Starting with dmPFC from eight rats per group, two animals were pooled to generate sufficient starting material (\~50 mg). This is the only instance of pooling in our studies. Subsequently, four samples per group were processed as individual biological replicates. After fixing the diced tissue in 1% formaldehyde for 15 min, the reaction was quenched with 0.125 M glycine for 5 min and centrifuged at 450 *g* for 5 min at 4 °C. Pellets were washed 2× in phosphate-buffered saline with Complete, EDTA-free Protease Inhibitor (CPI; Roche, Indianapolis, IN, USA) and suspended in cytoplasmic lysis buffer (10 mM Tris-HCl (pH 7.5), 10 mM NaCl, 0.2% NP-40, 1 × CPI). Cells were lysed with 25 strokes of a Dounce homogenizer (Kimble Chase, small clearance pestle) and centrifuged at 5500 *g* for 5 min at 4 °C. The nuclear pellet was resuspended in 450 μl of nuclear lysis buffer (50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 1% sodium dodecyl sulfate, 1 × CPI). DNA was sheared to an average length of 400 bp using a Misonix S-4000 microtip probe sonicator (25% amplitude, Farmingdale, NY, USA) for 4 × 20 s pulses with 20 s rest (three total cycles). After centrifugation at 15 700 *g* for 5 min at 4 °C, the supernatant was diluted 10 times with chromatin immunoprecipitation (ChIP) dilution buffer (0.01% sodium dodecyl sulfate, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl (pH 8.1), 167 mM NaCl, 1 × CPI). Two percent of each sample (genomic DNA input) was saved. Prewashed Protein A Dynabeads (50 μl; Life Technologies) were bound to 4 μg of either normal rabbit immunoglobulin G (Millipore, Billerica, MA, USA) or rabbit anti-H3K9me1 (Abcam, Cambridge, MA, USA) antibodies. The bead---antibody complex was washed and suspended in sample overnight at 4 °C. Each IP complex was washed sequentially with the following solutions: 1 × low salt buffer (0.1% sodium dodecyl sulfate, 0.1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.0), 150 mM NaCl), 1 × high salt buffer (NaCl replaced with 500 mM), 1 × LiCl (Millipore) and 2 × TE buffer. DNA complexes were eluted by adding 150 μl elution buffer (1% sodium dodecyl sulfate, 0.1 M NaHCO3 and 0.2 M NaCl). Samples were heated at 65 °C for 4 h to reverse crosslinks, followed by the addition of 50 μl Proteinase K mix (10 μg Proteinase K, 0.04 M EDTA, 0.2 M Tris-HCl (pH 8.0)) at 42 °C for 2 h. DNA was extracted using the QIAquick PCR Purification Kit (Qiagen, Valencia, CA, USA). Use of the H3K9me1 antibody was validated by quantitative real-time PCR (qPCR) showing enrichment of the ChIP signal compared with immunoglobulin G ([Figure 1a](#F1){ref-type="fig"}).

DNA sequencing {#S9}
--------------

H3K9me1 ChIP samples from control and postdependent rats, as well as each respective genomic DNA input samples (*n* = 4 per condition for a total of 16 samples), were processed for DNA sequencing by the Center for Genome Technology Sequencing Core (Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA). A High Sensitivity DNA Assay (Agilent Bioanalyzer 2100; Agilent Technologies, Santa Clara, CA, USA) was used to determine DNA concentration and shearing. Thirteen nanograms of input and ChIP-enriched DNA were used for 2 × 101 paired-end multiplexed library preparation using the NEBNext Ultra DNA Kit (New England Biolabs, Ipswich, MA, USA) and 13 cycles of PCR. The libraries were run on an Illumina HiSeq2000 using a PE rapid flow cell (San Diego, CA, USA).

Bioinformatic analysis {#S10}
----------------------

Read quality was evaluated using FastQC using default run parameters (<http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/>). Reads were mapped against RGSC6.0 using Bowtie 2 with no mismatches in the seed sequence allowed.^[@R36]^ Average alignment was 94.3 ± 0.003% (mean ± s.e.m.; [Supplementary Table 1](#SD2){ref-type="supplementary-material"}), which is comparable to previous studies of ChIP-sequencing analyses in the brain.^[@R37],[@R38]^ SICER (Spatial clustering for identification of ChIP-enriched region)^[@R39]^ was used for peak calling to capture the broad nature of H3K9 modifications.^[@R40]^ H3K9me1-enriched regions that exhibited statistically significant differences using a Benjamini-Hochberg false discovery rate correction between ChIP-control compared with ChIP-postdependent samples, but did not deviate between experimental conditions in the input samples were retained for further analysis. BEDTools^[@R41]^ was used to identify genes closest to and under enriched regions. We defined a 'gene region' to encompass 3000 bp upstream of the first exon genomic position through 500 bp downstream of the last exon genomic position (<http://github.com/Bohdan-Khomtch-ouk/geneXtender>). To assess the biological variability, edgeR^[@R42]^ was used to identify H3K9me1-enriched regions that exhibited significant differences in control as compared with postdependent samples (*n* = 4). The bioinformatic pipeline was initially validated using qPCR to verify differential H3K9me1 enrichment at the *Syt1* gene in control versus postdependent rats ([Figure 1b](#F1){ref-type="fig"}). As we previously reported for RNA-sequencing (RNA-seq) analysis,^[@R4]^ we used a nominal significance cutoff (*p*/*q*-value \< 0.05, fold change \> 1.2, *n* = 4) for our ChIP-seq analysis. WebGestalt gene ontology analysis was conducted using the default settings with the Rattus norvegicus genome (Rn6) as the reference background.^[@R43]^ Selected genes were visualized in the Integrative Genomics Viewer (Cambridge, MA, USA).^[@R44],[@R45]^

Western blotting {#S11}
----------------

Tissue was homogenized in lysis buffer (RIPA buffer, DTT; Cell Signaling, Danvers, MA, USA). Supernatant containing proteins was collected after 10 min centrifugation (10 000 g at 4°C). Protein concentration was assessed using the Pierce BCA Protein Assay Kit (Thermo Scientific, Rochester, NY, USA). Protein samples were denaturated at 70 °C for 10 min and run on a 4--12% Bis-Tris gel (NuPAGE Novex; Life Technologies, Grand Island, NY, USA), and then transferred to a polyvinylidene fluoride membrane (Millipore). The membrane was blocked with 5% nonfat dry milk and incubated overnight with the primary antibody (rabbit anti-H3K9me1 (1/1000; Abcam) and rabbit anti-H3 (1/1000; Cell Signaling). The membrane was washed with TBST and then incubated with secondary antibody anti-rabbit HRP (1:10 000; Cell Signaling) for 1 h. Detection and densitometric evaluations were performed using the ECL western blotting detection reagent (GE Healthcare, Piscataway, NJ, USA) and ImageJ software (Bethesda, MD, USA).

Laser capture microscopy and nanostring nCounter analysis {#S12}
---------------------------------------------------------

Arcturus XT (Life Technologies, Carlsbad, CA, USA) was used to perform laser capture microdissection. Cells showing lentiviral vector infection were captured by hand and transferred onto a cap (Capsuret Macro LCM Caps, Life Technologies, catalog number LCM0211) using a near-infrared laser pulse. RNA was extracted from caps using Single-Cell Lysis Kit following the manufacturer's instruction (Life Technologies, Grand Island, NY, USA). Given the very low amount of RNA collected, we measured mRNA expression using the nCounter Single-Cell Gene Expression assay following the manufacturer's instruction (Nanostring Technologies, Seattle, WA, USA).

Overview of behavioral testing {#S13}
------------------------------

Rats underwent a battery of alcohol-associated behavioral tests. First, they were tested for operant alcohol self-administration. This was followed by testing for aversion-resistant alcohol-seeking using quinine adulteration.^[@R46]^ Finally, baseline self-administration was re-established over a week after the last quinine test, extinguished, and rats were tested for stress-induced reinstatement of alcohol seeking.^[@R47]--[@R49]^

Alcohol self-administration {#S14}
---------------------------

Training and testing for operant self-administration of 10% alcohol in water were as described.^[@R50]^ Briefly, rats were trained to self-administer alcohol under a fixed ratio one with a 5 s timeout. Once self-administration rates were stable, rats received a microinjection of PRDM2-targeting or scrambled lentiviral vector directly into the dmPFC, and were allowed to recover for 1 week. Rats were then tested for alcohol self-administration after 1-week recovery.

Quinine adulteration {#S15}
--------------------

Rats were assessed for aversion-resistant alcohol consumption, a hallmark of compulsivity-like behavior. Alcohol was mixed with increasing concentration of quinine (0.005, 0.01, 0.025, 0.05 and 0.075 g l^−1^) during alcohol self-administration (one test session per quinine concentration). Compulsivity-like behavior was assessed by measuring % decreased reward after the addition of quinine.

Stress-induced reinstatement {#S16}
----------------------------

The experiment was performed as described previously.^[@R50]^ Briefly, extinction sessions started once self-administration rates were stable. During extinction, alcohol was no longer available, and operant responses had no programmed consequences. Stress-induced reinstatement testing started after operant responding was extinguished (\< 10 active lever presses/30 min session). Rats were tested four times for four different shock intensities (0.2, 0.4, 0.6 and 0.8 mA) in 15 min sessions. Each test was separated by 3 extinction days.

Statistical analysis {#S17}
--------------------

All data results were analyzed using analysis of variance (ANOVA), with factors for the respective analysis indicated in conjunction with its results. When appropriate, *post hoc* comparisons were performed using Newman---Keuls test. Hypergeometric probabilities were calculated using an online tool: <https://www.geneprof.org/GeneProf/tools/hypergeometric.jsp>. The accepted level of significance for all tests was *P* \< 0.05.

RESULTS {#S18}
=======

Expression of several epigenetic enzymes is persistently altered following a history of alcohol dependence {#S19}
----------------------------------------------------------------------------------------------------------

Using whole transcriptome sequencing analysis, we previously identified 784 genes with nominally significant persistent expression changes within the dmPFC after a history of alcohol dependence.^[@R4]^ Within this list, we found 22 genes that encode enzymes involved in histone methylation and acetylation, DNA methylation, bromodomain, chromodomain and PHD domain-containing reader proteins, as well as enzymes involved in chromatin remodeling ([Table 1](#T1){ref-type="table"}). These findings suggest that repeated cycles of alcohol intoxication followed by 3 weeks of protracted abstinence disrupt epigenetic processes.

A history of alcohol dependence decreases the expression and function of the histone methyltransferase PRDM2 {#S20}
------------------------------------------------------------------------------------------------------------

Although no studies have implicated a function for PRDM2 in the brain outside of cancer, microarray analysis of various human tissues suggested that *Prdm2* is strongly enriched in the PFC and other brain regions compared with peripheral tissues (<http://biogps.org>;[Figure 2a](#F2){ref-type="fig"}). *Prdm2* enrichment in the brain was confirmed using qPCR analysis of various tissues isolated from adult mouse ([Figures 2b and c](#F2){ref-type="fig"}). Given its enrichment in the PFC, we selected PRDM2 as a candidate for confirmation and functional validation.

qPCR analysis confirmed the downregulation of *Prdm2* expression in the dmPFC of postdependent rats ([Table 1](#T1){ref-type="table"} and [Figure 3a](#F3){ref-type="fig"}). *Prdm2* expression in the nucleus accumbens was not affected (scrambled: 100 ± 9.4% of control;Prdm2: 97.6 ± 8.6% of control; *P* \> 0.05), suggesting a region-specific effect. The decreased expression of *Prdm2* in postdependent dmPFC was restored by the DNA methyltransferase inhibitor RG-108 ([Figure 3a](#F3){ref-type="fig"};two-way ANOVA showed a significant effect of alcohol: F~(1--29)~ = 6.326, *P* = 0.02 and a significant interaction between alcohol and treatment: F~(1--29)~ = 8.177, *P* = 0.008; *n* = 6--10 per group). Although the baseline levels of *Prdm2* expression in control vehicle and RG-108-treated groups appeared to be slightly different, this was not statistically different (*P* = 0.2). As RG-108 was previously found to rescue both molecular and behavioral consequences of alcohol dependence in postdependent rats,^[@R4]^ this suggests that alcohol-induced *Prdm2* downregulation in the dmPFC may be driven by DNA hypermethylation. MeDIP analysis revealed no difference in DNA methylation level in the promoter region of *Prdm2* in the dmPFC of postdependent compared with control rats ([Supplementary Figure 2](#SD2){ref-type="supplementary-material"}). Taken together, these results suggest that alcohol-induced DNA hypermethylation downregulates *Prdm2* expression through intermediate molecular mechanisms.

We then examined whether *Prdm2* downregulation in the dmPFC of postdependent rats has functional consequences. Western blot analysis confirmed decreased monomethylation at H3K9 (H3K9me1) relative to total histone 3 levels in the dmPFC of postdependent compared with control rats ([Figure 3b](#F3){ref-type="fig"}; one-way ANOVA showed a significant effect of alcohol, F~(1--12)~ = 7.1; *P* \< 0.05; *n* = 7 per group). Total levels of histone 3 did not differ between the groups (*P* = 0.5). This supports the notion that the downregulation of *Prdm2* expression was also associated with decreased function.

PRDM2 is selectively expressed in neurons in dmPFC {#S21}
--------------------------------------------------

The expression of *Prdm2* in the normal brain has not previously been investigated. *In situ* hybridization using RNAscope technology revealed that *Prdm2* expression was colocalized with the neuronal marker *NeuN/RbFox3* ([Figures 4a--c](#F4){ref-type="fig"}). *Prdm2* was not expressed in cells that did not express *NeuN/RbFox3*, suggesting that *Prdm2* is specifically expressed in neurons.

ChIP-seq identifies genomic loci regulated by H3K9me1 in alcohol dependence {#S22}
---------------------------------------------------------------------------

To understand the persistent consequences of *Prdm2* downregulation that may confer susceptibility to alcohol dependence, we used ChIP followed by massively parallel DNA sequencing (ChIP-seq). Rather than isolating DNA directly associated with the PRDM2, whose dynamic interaction with target genes is subject to enzyme kinetics, we chose to examine more stable histone methylation changes that are functionally altered as a consequence of the known enzymatic activity of PRDM2. Because PRDM2 specifically monomethylates H3K9,^[@R26],[@R27]^ we used ChIP-seq to identify genomic loci subject to differential enrichment of H3K9me1 in the dmPFC of postdependent rats.

ChIP-seq analysis identified 3449 regions that exhibited decreased enrichment of H3K9me1 in postdependent rats. Only 1350 regions were more enriched in postdependent rats compared with controls, confirming an alcohol-induced global decrease of H3K9me1 consistent with PRDM2 downregulation ([Supplementary Table 2](#SD3){ref-type="supplementary-material"} and [Figure 5a](#F5){ref-type="fig"}). To minimize the potential for false positives and narrow our focus on H3K9me1 target genes that are functionally dysregulated in alcohol dependence, we overlaid our ChIP-seq findings with RNA-seq analysis of control versus postdependent dmPFC^[@R4]^ ([Figure 5b](#F5){ref-type="fig"}). We found 156 regions within 119 genes that were less enriched for H3K9me1 in postdependent rats and were also dysregulated by RNA-seq analysis ([Supplementary Table 3](#SD1){ref-type="supplementary-material"} and [Figure 5b](#F5){ref-type="fig"}). The majority of these genes (79%) were downregulated in postdependent rats ([Supplementary Table 3](#SD1){ref-type="supplementary-material"}). The degree of overlap between these two approaches was significantly more than that which would be expected by chance (hypergeometric distribution test *P* = 4.9 × 10^−23^), suggesting that H3K9me1 is an essential component of alcohol-induced transcriptional dysregulation.

Consistent with our results showing neuronal-specific *Prdm2* expression, cellular component analysis of these 119 overlapping genes revealed a significant enrichment of gene ontologies related to neuronal localization (coated vesicle, dendrite, neuron projection, excitatory synapse; [Table 2](#T2){ref-type="table"}). This analysis further implicated H3K9me1-mediated regulation of genes within the synaptic compartment (coated vesicle, cell junction, voltage-gated calcium channel complex, excitatory synapse, etc.). The molecular function analysis implicated regulation of calcium channel activity (calcium ion transmembrane transporter activity, calcium: cation antiporter activity, divalent inorganic cation transmembrane transporter activity, calcium channel activity, voltage-gated channel activity, etc.).

*Prdm2* knockdown mimics dependence-induced gene expression changes in dmPFC {#S23}
----------------------------------------------------------------------------

To identify the signaling pathways functionally affected by *Prdm2* dysregulation, we used laser capture microdissection, and specifically isolated cells transduced with *Prdm2* shRNA or scrambled control lentivirus in the dmPFC of non-dependent rats. Nanostring nCounter gene expression analysis^[@R51]^ of 340 genes previously found to be dysregulated in the dmPFC of postdependent rats^[@R4]^ or that have been strongly implicated in alcohol dependence in the literature confirmed knockdown of *Prdm2* in the dmPFC of 'PRDM2' compared with scrambled rats ([Figures 4d and e](#F4){ref-type="fig"}). There were 32 genes that were significantly affected by *Prdm2* knockdown ([Supplementary Table 4](#SD2){ref-type="supplementary-material"}; *n* = 8--9); nine of these overlapped with RNA-seq analysis from alcohol-dependent rats (*n* = 8--9; [Table 3](#T3){ref-type="table"}).

Of the overlapping genes affected by *Prdm2* knockdown and dysregulated in alcohol-dependent rats; four also exhibited regions of differential H3K9me1 enrichment between control and postdependent rats in the ChIP-seq analysis ([Table 3](#T3){ref-type="table"} and [Figures 5b--f](#F5){ref-type="fig"}), suggesting that these genes may be directly regulated by PRDM2 through methylation at H3K9. Again, this overlap was significantly more than would be expected by chance (hypergeometric distribution test *P* = 0.001), suggesting a true biological enrichment of high confidence PRDM2 target genes in alcohol dependence. Many of the regions of differential H3K9me1 enrichment lie within intron/exon boundaries or intronic regions of the target genes ([Table 3](#T3){ref-type="table"} and [Figures 5c--f](#F5){ref-type="fig"}).

Lentiviral knockdown of *Prdm2* expression in dmPFC of non-dependent rats mimics the behavioral consequences of alcohol dependence {#S24}
----------------------------------------------------------------------------------------------------------------------------------

To investigate a possible causal role of PRDM2 in alcohol-related behaviors, we examined non-dependent animals injected with the shRNA lentiviral vector targeting *Prdm2* in the dmPFC, and assessed them for alcohol self-administration, aversion-resistant alcohol consumption and stress-induced reinstatement of alcohol seeking, a model of relapse^[@R47],[@R48]^ ([Figure 6](#F6){ref-type="fig"}). *Prdm2* knockdown induced a range of behaviors characteristic of protracted abstinence following a prolonged history of alcohol dependence. First, we observed a modest but characteristic increase in operant alcohol self-administration (one-way ANOVA, main effect of group; scrambled versus PRDM2 rats; [Figures 6a and b](#F6){ref-type="fig"}; *n* = 22--20 per group; F~(1,40)~ = 5,9; *P* \< 0.02). Second, *Prdm2* knockdown increased resistance to quinine adulteration, suggesting a role of *Prdm2* in compulsive alcohol drinking (repeated-measures ANOVA: main effect of group; scrambled versus PRDM2 rats, [Figure 6b](#F6){ref-type="fig"}; *n* = 9--10 per group; F~(1,48)~ = 7; *P* = 0.02). Third, rats with suppressed *Prdm2* expression showed increased sensitivity and response to stress-induced reinstatement (repeated-measures ANOVA: main effect of group, scrambled versus PRDM2 rats; [Figure 6c](#F6){ref-type="fig"}; *n* = 9--10, F~(1,84)~ = 9.3; *P* = 0.006). *Prdm2* knockdown did not alter locomotor activity or sensitivity to shock intensity, showing that increased stress-induced reinstatement after inhibition of PRDM2 was not caused by altered locomotion or pain sensitivity. Finally, *Prdm2* knockdown did not affect sucrose self-administration ([Figure 6d--h](#F6){ref-type="fig"}), suggesting that PRDM2 specifically mediates alcohol-seeking behavior.

DISCUSSION {#S25}
==========

We report that a history of alcohol dependence results in persistently decreased expression of the H3K9 histone methyltransferase PRDM2 in the dmPFC of rats. Decreased expression of *Prdm2* was associated with decreased levels of the H3K9me1 mark, supporting the notion that downregulated expression of *Prdm2* results in decreased enzymatic activity. Our molecular analysis suggested that some of the gene expression changes observed after history of alcohol dependence are likely driven by *Prdm2* downregulation. Most importantly, behavioral analysis demonstrated that a viral-vector-mediated knockdown of *Prdm2* in the dmPFC of rats without a history of dependence resulted in several phenotypic traits that mimicked the consequences of a dependence history, and that are thought to be characteristic of alcohol addiction. Collectively, these findings support a role of *Prdm2* downregulation as a causal factor in alcohol-induced neuroadaptations.

Previous data from whole transcriptome analysis suggest that a history of alcohol dependence disrupts epigenetic processes.^[@R4]^ Epigenetic mRNAs dysregulated in alcohol-dependent rats oversee diverse epigenetic functions, including histone acetylation, histone methylation and non-enzymatic 'reader' function, suggesting a possible interplay between several epigenetic processes that takes place to regulate concerted and persistent gene expression changes observed after a history of alcohol dependence. A majority of the epigenetic enzymes were downregulated after chronic intermittent alcohol exposure. This is consistent with prior work, which has shown that a majority of dysregulated transcripts in the mPFC are downregulated after a history of alcohol dependence in human^[@R52]^ and postdependent rats.^[@R4]^ This observation could reflect a coordinated epigenetic network that represses global gene transcription through DNA methylation. Accordingly, we previously found that DNA methylation in postdependent rats is persistently increased in the mPFC.^[@R4]^

The wide-ranging dysregulation observed poses a considerable challenge for demonstrating a causal contribution by any individual enzyme to the behavioral phenotype induced by a history of dependence. Here, we focused on PRDM2, and examined its possible mechanistic contribution to several key behaviors induced by alcohol dependence. Previous studies suggest that *Prdm2* expression and its histone methyltransferase activity are dependent on the level of promoter DNA methylation.^[@R26],[@R29]^ Because alcohol-induced DNA hypermethylation has been shown to be involved in increased alcohol drinking,^[@R3],[@R4]^ we hypothesized that *Prdm2* might contribute to gene expression and behavioral changes underlying alcohol addiction. Accordingly, we found that the DNA methyltransferase inhibitor RG-108 directly infused into the dmPFC restored the levels of *Prdm2* in the postdependent rats, demonstrating a regulatory effect of DNA methylation on *Prdm2* levels. However, we did not observe changes in DNA methylation level in the promoter region of *Prdm2* itself following a history of dependence. This indicates an indirect regulation of *Prdm2* by alcohol-induced hypermethylation. Further investigation will be needed to identify the intermediate steps involved in this regulatory mechanism.

It has been shown that PRDM2 specifically monomethylates histone H3 on its lysine 9 residue.^[@R27]^ Both western blot and ChIP-seq analysis showed that H3K9me1 is decreased following a history of alcohol dependence. Our initial expression analysis only identified two H3K9-targeted epigenetic enzymes, *Prdm2* and *Phf2*, as being altered in control versus postdependent rats. Because *Phf2* is a histone demethylase, the observed downregulation of *Phf2* in postdependent rats would predict increased H3K9 methylation, which was not consistent with our observations. Our findings do not preclude the potential for involvement of other H3K9-targeted enzymes. However, the fact that *Prdm2* knockdown is sufficient to mimic several key behavioral and transcriptional characteristics of postdependent animals suggests that changes in activity of this enzyme may be a primary mechanism driving a transition into alcohol dependence.

Viral knockdown of *Prdm2* expression in the present study resulted in behaviors characteristic of rats with a history of dependence. For instance, rats with decreased expression of *Prdm2* in the dmPFC showed increased alcohol self-administration and increased aversion-resistant alcohol intake, as shown by increased resistance to quinine adulteration. Continued drug seeking despite aversive consequences, frequently referred to as 'compulsive drug seeking', is increasingly thought to be a hallmark of addiction and has been interpreted as a model for compulsive behavior.^[@R46],[@R53]--[@R55]^ Identifying molecular mechanisms that underlie aversion-resistant alcohol seeking is therefore critical for developing novel effective alcoholism medications. Our data suggest that *Prdm2* is a key player in modulating aversion-resistant alcohol intake. However, *Prdm2* knockdown did not fully prevent the suppression of alcohol intake observed as a result of quinine adulteration, suggesting that multiple genes work in concert to modulate aversion-resistant alcohol intake. In accordance with this hypothesis, we previously found that inhibition of synaptotagmin 2 expression was also able to increase aversion-resistant alcohol intake.^[@R4]^

*Prdm2* appears to regulate a broader range of alcohol-addiction-related behaviors, suggesting that it has a key role in the neuroadaptive processes within the dmPFC that are involved in the emergence of addiction. In addition to elevated self-administration and aversion-resistant intake, we also observed a role of PRDM2 in stress-induced reinstatement of alcohol seeking, an established model of relapse;^[@R48]^ *Prdm2* knockdown increased sensitivity to stress-induced reinstatement. In control experiments, this manipulation did not alter locomotor activity, sensitivity to shock intensity or sucrose seeking, making nonspecific behavioral effects of *Prdm2* unlikely as a cause of the behavioral findings. Collectively, these observations suggest that long-term repression of *Prdm2* is a key epigenetic mechanism contributing to a cluster of behaviors thought to be at the core of alcohol addiction.

To identify PRDM2 target genes that may underlie alcohol-seeking phenotypes, we overlaid H3K9me1 ChIP-seq and RNA-seq data from control versus postdependent dmPFC. In accordance with previous findings that H3K9me1 is associated with gene activation,^[@R56]^ the majority of genes that showed decreased H3K9me1 in postdependent rats were downregulated in post-dependent rats.^[@R4]^ The regions of differential H3K9me1 enrichment predominantly lie within gene bodies rather than promoter regions. While methylation at H3K9 in a gene promoter is commonly associated with transcriptional repression, methylation within the gene body promotes transcriptional elongation.^[@R57]^ Epigenetic regulation in regions outside of gene promoters has previously been shown to be affected by drug exposure. For example, differentially methylated DNA regions within introns, exons and intergenic intervals rather than within gene promoters was associated with parental THC exposure.^[@R58]^ Future studies will have to determine the functional implications of the regions subject to H3K9me1 regulation in the context of alcohol dependence. Another implication of our findings to be explored in future studies is whether these intronic regions of enrichment could mediate alternative promoter usage, cotranscriptional splicing of pre-mRNA or expression of noncoding transcripts that often arise from intronic regions.^[@R59]^

Pathway analysis of converging results from our epigenomics and transcriptomic molecular approaches suggested that PRDM2-mediated histone methylation may contribute to gene expression changes that alter synaptic functioning, particularly by affecting calcium channel activity. When our ChIP-seq and RNA-seq analysis of control versus postdependent rats were further overlaid with genes that were functionally dysregulated as a result of *Prdm2* knockdown *in vivo*, we identified four common genes, suggesting that long-term intermittent exposure to alcohol regulates these genes in part through *Prdm2* downregulation. Collectively, these observations support the hypothesis that *Prdm2* contributes to a reprogramming of the genome within the dmPFC that contributes to long-term neuroadaptations following a history of alcohol dependence.

Among the four overlapping genes, we found that the voltage-gated L- and T-type calcium channel subunits *Cacna1i* (Cav3.3) and *Cacna1d* (Cav1.3), respectively, were downregulated in *Prdm2* knockdown rats, paralleling alcohol dependence-induced downregulation of these genes. *Cacna1i, Cacna1d* and another PRDM2 target gene *Wnk2* were part of a DNA methylation-regulated transcriptional network that is disrupted in alcohol dependence.^[@R4]^ These genes are part of a gene network that may contribute to altered calcium release and neurotransmitter exocytosis in the mPFC of alcohol postdependent rats.^[@R4]^ Calcium channels have previously been implicated in altered patterns of cortical excitability that may underlie excessive alcohol intake and increase the propensity for relapse. For instance, non-human primates that chronically self-administer alcohol display plasticity in T-type calcium channel currents that is sensitive to periods of intoxication and withdrawal.^[@R60],[@R61]^ In addition to the calcium channel subunits *Cacna1i* and *Cacna1d, Wnk2* is also an essential regulator of neuronal excitability through regulation of cationchloride cotransporters.^[@R62]^ The fourth overlapping gene in our tripartite approach was *Bsn*, the Bassoon scaffolding protein that modulates calcium channel activity at the presynaptic active zone.^[@R63],[@R64]^ Our findings are in accordance with prior post-mortem studies, which have shown changes in the expression pattern of genes involved in synaptic neurotransmission.^[@R65],[@R66]^ Taken together, these studies and our results indicate impaired neurotransmitter release in the mPFC as a potential key mechanism that contributes to the emergence of alcohol addiction.

Importantly, H3K9me1 alone might, in some cases, be insufficient to regulate gene expression. For instance, Sims *et al*.^[@R67]^ showed that H3K9me1 cooperated with H4 lysine 20 monomethylation to silence gene expression. In another study, the number of neurons positive for H3 phosphorylation at serine 10 as well as acetylation at lysine 14 was low under basal conditions. However, both of these marks increased considerably after psychological stress, and this was associated with increased expression of *c-fos* and *egr-1*.^[@R68]^ A similar situation might be at play in our study. Under baseline condition, the H3K9me1 mark may not influence gene expression, but could render genes more susceptible to expression changes after alcohol or stress exposure. Furthermore, other genes identified in the *Prdm2* knockdown study that did not overlap with the H3K9me1 ChIP-seq analysis could be indirectly regulated by PRDM2 or could be regulated by an alternate function of PRDM2. For example, PRDM2 has been shown to act upstream of the repressive PRC2 complex in proliferating cells.^[@R69]^ More experiments are needed to fully understand how PRDM2 regulates gene expression in alcohol dependence.

In conclusion, we demonstrate a novel role of PRDM2 in behaviors thought to be critical for alcohol addiction. Our findings indicate that PRDM2-mediated reprogramming of the genome in neurons of the dmPFC is involved in multiple aspects of alcohol dependence, including increase in alcohol self-administration, compulsive-like drinking and stress-induced relapse. This broad spectrum of actions provides a strong rationale to explore PRMD2 itself or some of its downstream targets as candidate targets for novel alcoholism medications. Of note, although some of these therapies may be able to compensate for the neuroadaptive consequences of alcohol dependence, strategies that restore PRDM2 function might have a unique potential to reverse those changes, and promote a transition back to a preaddicted state.
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![(**a**) Validation of the histone 3 at the lysine 9 residue (H3K9me1) antibody. (**b**) Validation of the bioinformatic pipeline using quantitative real-time PCR (qPCR) to verify differential H3K9me1 enrichment at the *Syt1* gene in control versus postdependent rats. \**P* \< 0.05.](nihms891239f1){#F1}

![*Prdm2* expression in the brain and peripheral organs. (**a**) Human Affymetrix microarray data (<http://www.biogps.org>). (**b** and **c**) Quantitative real-time PCR (qPCR) of adult mouse tissues. The central nervous system tissue is shown in black bars and the peripheral tissues are shown in gray bars. \**P* \< 0.05.](nihms891239f2){#F2}

![(**a**) Repeated cycles of alcohol intoxication decreased mRNA levels of *Prdm2*. The DNA methyltransferase (DNMT) inhibitor RG-108 significantly restored levels of *Prdm2* (*n* = 6--10;two-way analysis of variance (ANOVA): main effect of group;control versus postdependent;F~(1--29)~ = 6.3; *P* = 0.02; *post hoc* analysis control vehicle versus postdependent vehicle; *P* = 0.008; No significant difference between postdependent RG-108 versus control RG-108 or postdependent RG-108 versus control vehicle). The mean values (± s.e.m.) of control rats are shown in black bars. The mean values (± s.e.m.) of postdependent rats are shown in gray bars. mRNA expression is presented as % change from control/vehicle values. (**b**) Western blot analysis shows that monomethylation at H3K9 (H3K9me1) is significantly reduced in the dorsomedial prefrontal cortex (dmPFC) of postdependent rats (*n* = 7 per group;one-way ANOVA;main effect of group;control versus postdependent; F~(1--12)~ = 7.1; *P* \< 0.05). ^\#^*P* \< 0.05, control versus postdependent rats.](nihms891239f3){#F3}

![(**a--c**) Expression of PRDM2 in rat dorsomedial prefrontal cortex (dmPFC) measured by RNAscope. Red dots show the expression of the neuronal marker *RbFox3*, and the green dots show the expression of *Prdm2* and blue labeling represents DAPI (4′,6-diamidino-2-phenylindole) staining. (**d**) *Prdm2* mRNA expression is decreased after *Prdm2* knockdown. (**e**) Site of virus injection. \**P* \< 0.05; Scrambled versus PRDM2.](nihms891239f4){#F4}

![Tripartite approach implicates high confidence targets of PRDM2 in alcohol dependence. (**a**) Chromatin immunoprecipitation-sequencing (ChIP-seq) analysis identified genomic regions subjected to histone 3 at the lysine 9 residue (H3K9me1) epigenetic regulation in control versus postdependent dorsomedial prefrontal cortex (dmPFC). (**b**) Overlay of ChIP-seq and RNA-sequencing (RNA-seq) analysis from control versus postdependent dmPFC identified 119 common genes. These analyses were further overlaid with NanoString gene expression analysis from rat mPFC subjected to PRDM2 short hairpin RNA (shRNA) compared with a scramble control (hypergeometric distribution test *P* = 0.001). (**c--f**) ChIP-seq data from the four common genes implicated in all three approaches. Top tracks show the UCSC gene relative to the scale shown at the right. The location of the region of differential H3K9me1 enrichment is denoted by the red box below the gene track. The bottom tracks show the Spatial clustering for identification of ChIP-enriched region (SICER)-filtered read enrichment of H3K9me1 ChIP data for the control rats (gray) and postdependent rats (light red) overlaid.](nihms891239f5){#F5}

![Lentiviral-mediated knockdown of *Prdm2* in the dmPFC alters addiction-like behaviors (**a--c**): Voluntary alcohol-self-administration (**a**) (One way ANOVA: main effect of group;scrambled versus PRDM2 rats;F~(1,40)~ = 5.9; *P* \< 0.02), compulsive drinking in a quinine adulteration task (**b**) (Repeated-measure ANOVA: main effect of group;Scrambled versus PRDM2 rats;F~(1,48)~ = 7; *P* = 0.02), and stress-induced relapse (**c**) (Repeated-measure ANOVA;main effect of group;scrambled versus PRDM2 rats F~(1,84)~ = 9.3; *P* = 0.006). Lentiviral knockdown of *Prdm2* did not affect control behaviors (**d--h**) such as locomotor activity (**d**), average velocity (**e**), sensitivity to shock intensity (**f**), sucrose self-administration (**g**), nor rat weight (**h**). The mean values (± s.e.m.) of scrambled rats are shown in black bars. The mean values (± s.e.m.) of PRDM2 knockdown rats are shown in gray bars (*n* = 9--10). \**p* \< 0.05, scrambled versus PRDM2 rats.](nihms891239f6){#F6}

###### 

Genes with known chromatin remodeling functions that were dysregulated according to RNA-seq data from the dmPFC of control versus postdependent rats

  Gene symbol   Epigenetic class              Target site or gene function             Fold change   *P*-value
  ------------- ----------------------------- ---------------------------------------- ------------- -----------
  *Smarce1*     *Chromatin remodeling*        SWI/SNF complex                          −3.02         0.0003
  *Brd4*        *Bromodomain reader*          H4K5/8/12/16                             −1.95         0.006
  *Tet1*        *DNA demethylase*             5 hmc                                    −2.06         0.007
  *Phf2*        *Histone demethylase*         H3K9me2                                  −1.95         0.012
  *Trim33*      *Bromodomain reader*          E3 Ub ligase, H3K9me3, H3K18ac             1.35        0.016
  *Brpf1*       *Histone acetyltransferase*   H2AK5, H4K12, H3K14                      −1.55         0.017
  *Chd8*        *Chromodomain reader*         DNA helicase                             −1.36         0.017
  *Srcap*       *Chromatin remodeling*        SWI/SNF complex, H2AZ/H1AZ exchange      −1.69         0.020
  *Hdac7*       *Histone deacetylase*         Class IIa HDAC                           −2.44         0.023
  *Brd3*        *Bromodomain reader*          H4K5/8/12/16                             −1.48         0.024
  *Mll5*        *Histone methyltransferase*   H3K4                                     −1.39         0.026
  *Dot1l*       *Histone methyltransferase*   H3K79                                    −2.09         0.026
  *Tet3*        *DNA demethylase*             5 hmc                                    −1.73         0.027
  *Dpf2*        *PhD domain reader*           Acetylated histones                      −1.53         0.027
  *Kdm6b*       *Histone demethylase*         H3K27                                    −2.33         0.029
  *Chmp1b*      *Chromatin remodeling*        ESCRT-II complex                           1.41        0.030
  *Prdm2*       *Histone methyltransferase*   H3K9me1                                  −1.51         0.032
  *Chd4*        *Chromodomain reader*         NuRD chromatin remodeling complex        −1.49         0.039
  *Ino80*       *Chromatin remodeling*        SNF2/SWI2 helicase family                −1.35         0.040
  *Myst3*       *Histone acetyltransferase*   H3 acetylation                           −1.77         0.041
  *Ep300*       *Histone acetyltransferase*   All core histones, non-histone targets   −1.33         0.042
  *Prmt5*       *Histone methyltransferase*   H3R8, H4R3, H2A, non-histone targets       1.31        0.050

Abbreviation: dmPFC, dorsomedial prefrontal cortex; RNA-seq, RNA-sequencing.

###### 

GO functional enrichment analysis of 119 overlapping genes implicated in H3K9me1 ChIP-seq and RNA-seq analysis of post-dependent rat dmPFC.

  Category             GO                                                             GO ID        Number of hit genes versus expected number   Ratio of enrichment   *P*-value
  -------------------- -------------------------------------------------------------- ------------ -------------------------------------------- --------------------- -----------
  Cellular component   Coated vesicle                                                 GO:0030135   6/1.33                                         4.51                0.00005
                       Dendrite                                                       GO:0030425   8/2.77                                         2.89                0.0001
                       Cell junction                                                  GO:0030054   11/4.10                                        2.69                0.0002
                       Golgi apparatus part                                           GO:0044431   7/2.26                                         3.10                0.0002
                       Voltage-gated calcium channel complex                          GO:0005891   2/0.15                                       13.67                 0.0002
                       Golgi stack                                                    GO:0005795   4/0.56                                         7.15                0.0003
                       Neuron projection                                              GO:0043005   14/5.21                                        2.69                0.0004
                       Organelle subcompartment                                       GO:0031984   3/0.41                                         7.37                0.0004
                       Excitatory synapse                                             GO:0060076   2/0.15                                       13.10                 0.0004
                       *Trans*-Golgi network transport vesicle                        GO:0030140   2/0.13                                       14.98                 0.0004
  Molecular function   Methylcytosine dioxygenase activity                            GO:0070579   2/0.03                                       75.32                 0.0003
                       SH3 domain binding                                             GO:0017124   5/0.64                                         7.85                0.0004
                       Calcium ion transmembrane transporter activity                 GO:0015085   5/0.64                                         7.76                0.0005
                       Calcium:cation antiporter activity                             GO:0015368   2/0.05                                       43.04                 0.0009
                       Divalent inorganic cation transmembrane transporter activity   GO:0072509   5/0.82                                         6.12                0.0014
                       Protein domain-specific binding                                GO:0019904   11/3.79                                        2.90                0.0014
                       Calcium channel activity                                       GO:0005262   4/0.54                                         7.44                0.0021
                       Inositol phosphate phosphatase activity                        GO:0052745   2/0.09                                       23.17                 0.0032
                       Phosphatase activity                                           GO:0016791   6/1.53                                         3.91                0.0044
                       Voltage-gated channel activity                                 GO:0022832   5/1.10                                         4.54                0.0050
  Biological process   Glomerulus vasculature morphogenesis                           GO:0072103   2/0.03                                       60.85                 0.0007
                       Positive regulation of smooth muscle cell proliferation        GO:0048661   5/0.39                                       12.68                 0.0022
                       Artery development                                             GO:0060840   4/0.34                                       11.93                 0.0024
                       Aorta morphogenesis                                            GO:0035909   3/0.11                                       26.84                 0.0026
                       Regulation of smooth muscle cell migration                     GO:0014910   4/0.26                                       15.60                 0.0065
                       Muscle cell migration                                          GO:0014812   4/0.30                                       13.23                 0.0075
                       Comma-shaped body morphogenesis                                GO:0072049   2/0.03                                       60.85                 0.0078
                       Regulation of smooth muscle cell proliferation                 GO:0048660   5/0.63                                         7.92                0.0078
                       Artery morphogenesis                                           GO:0048844   4/0.28                                       14.15                 0.0093
                       Negative regulation of chromatin silencing                     GO:0031936   2/0.03                                       60.85                 0.0101

Abbreviations: dmPFC, dorsomedial prefrontal cortex; GO, gene ontology; H3K9me1, histone 3 at the lysine 9 residue; RNA-seq, RNA-sequencing.

###### 

Overlapping dmPFC gene expression changes caused by a history of alcohol dependence (RNA-seq data from PD versus CTL), as well as knockdown of PRDM2 (*n* = 8--9)

  Gene name   RNA-seq: PD versus CTL   PRDM2 shRNA versus scramble   H3K9me1 ChIP: PD versus CTL                            
  ----------- ------------------------ ----------------------------- ----------------------------- ------- ------- -------- ----------------------
  *Abcd3*       1.27                   0.03                            −17.5                       0.02                     
  *Bsn*       −1.52                    0.03                          −143.50                       0.04    −1.32   0.008    Intron 1/11
                                                                                                           −2.21   0.02     Intron 1/11
  *Cacna1d*   −1.66                    0.02                              −5.56                     0.01    −1.27   0.005    Intron 8/50
                                                                                                           −1.51   0.006    Intron 9/50
  *Cacna1i*   −1.71                    0.01                              −6.75                     0.03    −1.27   0.0006   Introns 25/28--27/38
  *Helz*      −1.53                    0.01                              −4.82                     0.04                     
  *Ncor2*     −1.78                    0.01                              −3.74                     0.02                     
  *Nop14*       1.42                   0.02                              −8.27                     0.01                     
  *Rab3c*       1.41                   0.02                              62.73                     0.01                     
  *Wnk2*      −1.99                    0.008                           −11.55                      0.004   −2.06   0.01     Intron 1/26

Abbreviations: ChIP, chromatin immunoprecipitation; CTL, control; dmPFC, dorsomedial prefrontal cortex; H3K9me1, histone 3 at the lysine 9 residue; PD, postdependent; shRNA, short hairpin RNA. Several of these genes may be direct targets of PRDM2, since EdgeR significance analysis of ChIP-seq data identified differential enrichment of H3K9me1 at the indicated genomic loci in the context of alcohol dependence (*n* = 4).
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